Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $573.63 Average PT from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned an average rating of “Moderate Buy” from the twenty-seven ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nineteen have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $571.28.

Several analysts recently issued reports on ISRG shares. Truist Financial cut their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a report on Wednesday, April 15th. UBS Group lowered their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Jefferies Financial Group lowered their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Finally, Robert W. Baird increased their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd.

Intuitive Surgical Trading Up 1.3%

Shares of NASDAQ:ISRG opened at $416.55 on Thursday. Intuitive Surgical has a 1 year low of $396.68 and a 1 year high of $603.88. The business has a fifty day simple moving average of $442.17 and a 200 day simple moving average of $494.54. The firm has a market cap of $147.53 billion, a price-to-earnings ratio of 50.49, a P/E/G ratio of 3.28 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the company earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical will post 8.57 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director directly owned 239 shares of the company’s stock, valued at $113,156.94. This represents a 67.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock valued at $3,059,135 over the last three months. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Defilade Capital Management L.P. grew its position in shares of Intuitive Surgical by 48.2% in the first quarter. Defilade Capital Management L.P. now owns 67,681 shares of the medical equipment provider’s stock valued at $31,200,000 after purchasing an additional 22,019 shares during the last quarter. FAS Wealth Partners Inc. grew its position in shares of Intuitive Surgical by 1.0% in the first quarter. FAS Wealth Partners Inc. now owns 5,282 shares of the medical equipment provider’s stock valued at $2,435,000 after purchasing an additional 52 shares during the last quarter. Pine Valley Investments Ltd Liability Co grew its position in shares of Intuitive Surgical by 30.0% in the first quarter. Pine Valley Investments Ltd Liability Co now owns 2,350 shares of the medical equipment provider’s stock valued at $1,083,000 after purchasing an additional 543 shares during the last quarter. Evansbrook LLC grew its position in shares of Intuitive Surgical by 5.4% in the first quarter. Evansbrook LLC now owns 1,651 shares of the medical equipment provider’s stock valued at $761,000 after purchasing an additional 85 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in shares of Intuitive Surgical by 0.8% in the first quarter. Parallel Advisors LLC now owns 40,733 shares of the medical equipment provider’s stock valued at $18,778,000 after purchasing an additional 321 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.